<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05616767</url>
  </required_header>
  <id_info>
    <org_study_id>000017185</org_study_id>
    <nct_id>NCT05616767</nct_id>
  </id_info>
  <brief_title>Prevention and Screening for Early Detection of HPV-related Cancers in Gay and Bisexual Men in Tanzania</brief_title>
  <official_title>Prevention and Screening for Early Detection of HPV-related Cancers in Gay and Bisexual Men in Tanzania</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Minnesota</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The long-term objective of the parent study is &quot;to reduce the effects of OPCa through&#xD;
      secondary prevention (i.e., early detection, diagnosis and treatment referral).&quot; Consistent&#xD;
      with this, this supplement will test HPV-related interventions tailored for Sexual Minority&#xD;
      Men (SMM). Acceptability, feasibility and preliminary effectiveness of a smart-phone&#xD;
      delivered Oropharyngeal Cancer (OPCA) self-assessment tool will be assessed. Given that&#xD;
      homosexuality is stigmatized and criminalized in Tanzania, and that cell phone use is the key&#xD;
      way SMM communicate in Tanzania, a self-assessment screening cell phone intervention holds&#xD;
      particular promise for SMM in Tanzania but warrants separate evaluation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 30, 2022</start_date>
  <completion_date type="Anticipated">September 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>assess screening practices of hrHPV-related OPCa</measure>
    <time_frame>Baseline</time_frame>
    <description>Questionaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acceptability and feasibility of teaching SMM in Tanzania to conduct self-exams</measure>
    <time_frame>baseline to 6 months</time_frame>
    <description>Questionaire to assess post-test selfie evaluations, Scores: 0= was not trained; 1= was trained; 2=took a selfie; 3= clear selfie</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acceptability and feasibility of hrHPV vaccination</measure>
    <time_frame>baseline</time_frame>
    <description>percentage of individuals recruited for aim 1 who request HPV vaccination, Scores are 0=no vaccination; 1=first vaccination; 2= second vaccination; 3=third vaccination</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acceptability and feasibility of hrHPV vaccination</measure>
    <time_frame>1 month</time_frame>
    <description>percentage of individuals recruited for aim 1 who request HPV vaccination, Scores are 0=no vaccination; 1=first vaccination; 2= second vaccination; 3=third vaccination</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the acceptability and feasibility of hrHPV vaccination</measure>
    <time_frame>6 months</time_frame>
    <description>percentage of individuals recruited for aim 1 who request HPV vaccination, Scores are 0=no vaccination; 1=first vaccination; 2= second vaccination; 3=third vaccination</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>HPV</condition>
  <arm_group>
    <arm_group_label>Training on self-screening and HPV vaccination administration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>teaching SMM in Tanzania to conduct self-exams for oropharyngeal hrHPV-associated cancers using cellphone-mediated oral selfies, and administering the HPV vaccination series (with 2 and 6-8 month follow-up) to those who request it</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Training on self-screening and HPV vaccination administration</intervention_name>
    <description>Participants will be taught how to do self-screening for HPV-associated cancers using Training on self-screening and HPV vaccination administration. They will also be given HPV vaccination series.</description>
    <arm_group_label>Training on self-screening and HPV vaccination administration</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age over 18&#xD;
&#xD;
          -  gay or bisexual men&#xD;
&#xD;
          -  speak Kiswahili or English&#xD;
&#xD;
          -  resident in Dar es Salam&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>gay or bisexual men</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Michael Ross, MD, PhD</last_name>
    <phone>612-625-1500</phone>
    <email>mwross@umn.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dar es Salaam</name>
      <address>
        <city>Dar es Salaam</city>
        <country>Tanzania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Ross, MD,PhD</last_name>
      <phone>612-625-1500</phone>
      <email>mwross@umn.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>Tanzania</country>
  </location_countries>
  <verification_date>February 2023</verification_date>
  <study_first_submitted>October 28, 2022</study_first_submitted>
  <study_first_submitted_qc>November 8, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 15, 2022</study_first_posted>
  <last_update_submitted>February 20, 2023</last_update_submitted>
  <last_update_submitted_qc>February 20, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">February 22, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

